Literature DB >> 17157313

The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition.

Tara L Davis1, John R Walker, Patrick J Finerty, Farrell Mackenzie, Elena M Newman, Sirano Dhe-Paganon.   

Abstract

Calpains are calcium activated cysteine proteases found throughout the animal, plant, and fungi kingdoms; 14 isoforms have been described in the human genome. Calpains have been implicated in multiple models of human disease; for instance, calpain 1 is activated in the brains of individuals with Alzheimer's disease, and the digestive tract specific calpain 9 is down-regulated in gastric cancer cell lines. We have solved the structures of human calpain 1 and calpain 9 protease cores using crystallographic methods; both structures have clear implications for the function of non-catalytic domains of full-length calpains in the calcium-mediated activation of the enzyme. The structure of minicalpain 1 is similar to previously solved structures of the protease core. Auto-inhibition in this system is most likely through rearrangements of a central helical/loop region near the active site cysteine, which occlude the substrate binding site. However, the structure of minicalpain 9 indicates that auto-inhibition in this enzyme is mediated through large intra-domain movements that misalign the catalytic triad. This disruption is reminiscent of the full-length inactive calpain conformation. The structures of the highly conserved, ubiquitously expressed human calpain 1 and the more tissue specific human calpain 9 indicate that although there are high levels of sequence conservation throughout the calpain family, isolated structures of family members are insufficient to explain the molecular mechanism of activation for this group of proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157313     DOI: 10.1016/j.jmb.2006.11.037

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.

Authors:  Katherine J Wert; Susanne F Koch; Gabriel Velez; Chun-Wei Hsu; MaryAnn Mahajan; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

Review 2.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

3.  Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.

Authors:  Jirong Long; Wei Zheng; Yong-Bing Xiang; Felicity Lose; Deborah Thompson; Ian Tomlinson; Herbert Yu; Nicolas Wentzensen; Diether Lambrechts; Thilo Dörk; Natalia Dubrowinskaja; Marc T Goodman; Helga B Salvesen; Peter A Fasching; Rodney J Scott; Ryan Delahanty; Ying Zheng; Tracy O'Mara; Catherine S Healey; Shirley Hodgson; Harvey Risch; Hannah P Yang; Frederic Amant; Nurzhan Turmanov; Anita Schwake; Galina Lurie; Jone Trovik; Matthias W Beckmann; Katie Ashton; Bu-Tian Ji; Ping-Ping Bao; Kimberly Howarth; Lingeng Lu; Jolanta Lissowska; Lieve Coenegrachts; Dilyara Kaidarova; Matthias Dürst; Pamela J Thompson; Camilla Krakstad; Arif B Ekici; Geoffrey Otton; Jiajun Shi; Ben Zhang; Maggie Gorman; Louise Brinton; An Coosemans; Rayna K Matsuno; Mari K Halle; Alexander Hein; Anthony Proietto; Hui Cai; Wei Lu; Alison Dunning; Douglas Easton; Yu-Tang Gao; Qiuyin Cai; Amanda B Spurdle; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

4.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

5.  Small-angle X-ray scattering of calpain-5 reveals a highly open conformation among calpains.

Authors:  Lokesh Gakhar; Alexander G Bassuk; Gabriel Velez; Saif Khan; Jing Yang; Stephen H Tsang; Vinit B Mahajan
Journal:  J Struct Biol       Date:  2016-07-27       Impact factor: 2.867

6.  Computational investigation of the key factors affecting the second stage activation mechanisms of domain II m-calpain.

Authors:  Gaurav Bhatti; Lakshmi Jayanthi; Pamela VandeVord; Yeshitila Gebremichael
Journal:  J Mol Model       Date:  2012-10-10       Impact factor: 1.810

Review 7.  Calpain-2 as a therapeutic target for acute neuronal injury.

Authors:  Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2017-11-28       Impact factor: 6.902

8.  Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells.

Authors:  Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  Exp Cell Res       Date:  2009-11-10       Impact factor: 3.905

9.  Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense.

Authors:  Shoji Hata; Manabu Abe; Hidenori Suzuki; Fujiko Kitamura; Noriko Toyama-Sorimachi; Keiko Abe; Kenji Sakimura; Hiroyuki Sorimachi
Journal:  PLoS Genet       Date:  2010-07-29       Impact factor: 5.917

10.  Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.

Authors:  Jin Qian; Dominic Cuerrier; Peter L Davies; Zhaozhao Li; James C Powers; Robert L Campbell
Journal:  J Med Chem       Date:  2008-08-15       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.